The native just-in-time compiler in Python 3.15 can speed up code by as much as 20% or more, although it’s still experimental ...

随着大模型开始被用于长时程任务，比如深度研究、代码仓库理解、跨文档信息整合，模型一次性需要面对的输入，已经不再是几十万 token，而是数千万甚至上亿 token。

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

新年伊始，MIT CSAIL 的一纸论文在学术圈引发了不小的讨论。Alex L． Zhang 、 Tim Kraska 与 Omar Khattab 三位研究者在 arXiv 上发布了一篇题为《Recursive Language ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

It has been about a month since the last earnings report for Recursion Pharmaceuticals (RXRX). Shares have added about 6.5% in that time frame, outperforming the S&P 500. But investors have to be ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

2025年的最后一天， MIT CSAIL提交了一份具有分量的工作。当整个业界都在疯狂卷模型上下文窗口（Context ...